Skip to main content
Top

Current Hematologic Malignancy Reports

Issue 3/2020

Content (8 Articles)

Daratumumab Multiple Myeloma (P Kapoor, Section Editor)

Updates in the Diagnosis and Management of AL Amyloidosis

Joselle Cook, Eli Muchtar, Rahma Warsame

Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemias (N Jain, Section Editors)

Frontline Therapy of Chronic Lymphocytic Leukemia: Changing Treatment Paradigm

Manju Sengar, Hasmukh Jain, Akhil Rajendra, Karthik Rengaraj, Jayashree Thorat

Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemias (N Jain, Section Editor)

Management of Ibrutinib Toxicities: a Practical Guide

Masa Lasica, Constantine S. Tam

Myelodysplastic Syndrome Molecular Testing and Diagnostics (J Khoury, Section Editor)

Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies

Arash Ronaghy, Richard K. Yang, Joseph D. Khoury, Rashmi Kanagal-Shamanna

Acute Myeloid Leukemia Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)

Artificial Intelligence in Hematology: Current Challenges and Opportunities

Nathan Radakovich, Matthew Nagy, Aziz Nazha

Lymphoma T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor)

Radiogenomics and Its Role in Lymphoma

Saman Khan, Sohaib Naim, Rania Bilwani, Amirah Salem, David Gorlin, Ahmad Muhammad, Maryam Gul, Muhammad H. Imam, Ammar Chaudhry

Lymphoma T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor)

Treatment of Aggressive B Cell Lymphomas: Updates in 2019

Patrizia Mondello, Grzegorz S. Nowakowski

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine